ClinicalTrials.Veeva

Menu

Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals. (MAPS)

A

Assistance Publique - Hôpitaux de Paris

Status

Not yet enrolling

Conditions

Chronic Disease
Delivery Simple, Standardized & Redundant Message to Patient
Training Group, Sensitivity
Therapeutic Adherence

Treatments

Other: Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action for therapeutic adherence.

Study type

Interventional

Funder types

Other

Identifiers

NCT06748118
APHP230810
PREPS-22-0004 (Other Grant/Funding Number)
2024-A00701-46 (Other Identifier)
DR-2024-271 (Other Identifier)

Details and patient eligibility

About

The primary objective in this study is to achieve a 15% 6-month improvement in therapeutic adherence among patients with chronic pathologies, thanks to a simple, standardized and redundant message delivered by healthcare professionals during consultations/interviews Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action concerning therapeutic adherence. This message is delivered with the aim of modifying the patient's behavior with regard to treatment intake.

Full description

This project will enable us to adapt or even modify the practices of healthcare professionals, by making management recommendations to improve patients' adherence to treatment during their consultations/interviews, and throughout their entire course of care. This project will increase the benefit/risk ratio of treatments and reduce the waste of healthcare resources.

For patients, their participation by filling in the therapeutic adherence self-questionnaire will enable them to become active players in the management of their treatment.

If the results of our study prove positive, this will lead to a new, optimized organization of patient care.

Enrollment

1,210 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (age ≥ 18 years)
  • Affiliated to the French social security system
  • Followed in hospital for a chronic pathology within a formalized care pathway
  • Having signed a consent form to participate in the study.

Exclusion criteria

  • Patients included in the control period.
  • Patients under guardianship.
  • Pregnant or breast-feeding patients.
  • Patients taking part in research on compliance

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

Single Blind

1,210 participants in 2 patient groups

Intervention period
Experimental group
Description:
Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action for therapeutic adherence. During this period, the message will be delivered to the patient by each of the healthcare professionals involved in his or her hospital care. It will be formalized by a checklist that will enable them to reformulate the 3 points defined as key elements of therapeutic adherence. Each healthcare professional is free to deliver this message at any time during their consultation/interview with the patient. They will be asked to note the date and tick off each point on the checklist. The intervention period will take place after the control and wash-out periods, and after healthcare professionals have been trained in the intervention.
Treatment:
Other: Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action for therapeutic adherence.
Control period
No Intervention group
Description:
The control period is the period before healthcare professionals are trained in the intervention. Patients included during this period will not receive the simple, standardized and redundant message.

Trial contacts and locations

10

Loading...

Central trial contact

Tiffany MARTIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems